Pfizer Faces Lipitor Competition as Patent Expires

Pfizer Faces Lipitor Competition as Patent Expires Play

Nov. 1 (Bloomberg) -- Pfizer Inc., the world's largest drugmaker, is focused on bringing new drugs to market and preparing for generic competition to Lipitor, the world’s best-selling drug with $10.7 billion in annual sales. Lipitor loses patent protection this month. Shannon Pettypiece reports on Bloomberg Television's "InsideTrack." (Source: Bloomberg)

  • On Air Now

    Trendsetters: Technology. Culture. Design. Watch Now

  • Next

    Puerto Rico: Island of Debt and Opportunity

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus